An Expanded Access Trial in Japan to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment Options
Clinical trial NCT05200247 · COMPLETED
Trial details
- NCT number
- NCT05200247
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-17
- Primary completion
- 2023-03-20
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.